Keywords
SaMD
MedTech
MDSW
How to Cite
Abstract
The aim of this paper is to analyze the changes introduced by Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices regarding the qualification and classification of software as a medical device. The results of this analysis allow an attempt to answer the question of how far the new regulations ensure a balance between protecting the patient and user and ensuring the availability of innovative medical technologies. The assessment of the new regulations in the EU was made against the background of the regulations adopted for the approval of software as a medical device in the United States. Conclusions arising from the above assessment also include the author's proposal to amend the new regulations as a de lege ferenda postulate.
References
Bibliografia
Baird P., Cobbaert K. Software as a medical device. A comparison of the EU’s approach with
the US’s approach, https://www.bsigroup.com/globalassets/meddev/localfiles/fr-fr/whitepapers/md-wp-software.pdf.
Berensmann M., Gratzfeld M. Anforderungen für die CE-Kennzeichnung von Apps und
Wearables, „Bundesgesundheitsblatt - Gesundheitsforschung – Gesundheitsschutz” 2018, Nr. 61.
Grell A.-S. SaMD versus MDSW: what’s the difference between Software as a Medical
Device and Medical Device SoftWare?, 1 września 2021 r., https://qbdgroup.com/en/blog/samd-mdsw-difference.
Hartung W, Schalago J., Rossi C., Pavkov R. Software as a Medical Device Fundamentals,
„Pharmaceutical Engineering”, Tom 41, Nr 4 (2021).
Helios J., Jedlecka W. Wykładnia prawa Unii Europejskiej ze stanowiska teorii prawa,
Wrocław 2018.
Jasiński A. H. Komercjalizacja jako element modelu procesowego innowacji [w:] Innowacje i
komercjalizacja w biotechnologii, Trzmielak D. M. (red.), Wydawnictwo Uniwersytetu Łódzkiego, Łódź 2013.
Kupis M. Stosowanie przepisów Rozporządzenia Parlamentu Europejskiego i Rady (UE)
/745 do sztucznej inteligencji, “Przegląd Prawa Medycznego”, Tom 4 Nr 1 (2022).
Prütting J., Wolk T. Software unter dem Regime der europäischen Medizinprodukteverordnung
(2017/745/EU), „Medizinrecht” 2020, Nr 38.
Vollebregt, E. Enriched MDR and IVDR [e-book] wyd. 1, 2021.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Patryk Kałczyński